NCT02853955

MitraClip® After Surgical Mitral Valve Repair

MitraClip® for the Treatment of Recurrent Severe Mitral Regurgitation After Surgical Mitral Valve Repair

• Status: Unknown
• Phase: —
• Study type: Observational
• Enrollment: 30 (estimated)
• Sponsor: LMU Klinikum · Academic / Other
• Sex: All
• Age: 18 Years – 95 Years
• Healthy volunteers: Not accepted

Summary

Percutaneous edge-to-edge repair of the mitral valve has been shown to be a safe and effective alternative treatment option for selected patients at high risk for cardiac surgery. Patients with recurrent mitral regurgitation after surgical mitral valve repair (sMVR) are per se at increased risk for another cardiac surgery. The purpose of this multicenter retrospective analysis of patients treated with a MitraClip® after sMVR, is to evaluate the effectiveness and durability of this minimally invasive treatment option in this subset of patients.

Detailed description

In this multicenter retrospective analysis of MitraClip® cases after MVR the effectiveness and durability of this minimally invasive treatment option in this subset of patients will be evaluated.

Conditions

• Mitral Regurgitation

Interventions

Type	Name	Description
DEVICE	Percutaneous edge-to-edge repair of the mitral valve	MitraClip in patients with recurrent MI after surgical mitral valve repair.

Timeline

• Start date: 2016-05-01
• Primary completion: 2016-09-01
• Completion: 2016-11-01
• First posted: 2016-08-03
• Last updated: 2016-09-01

Locations

1 site across 1 country: Germany